Manish Goel
About Manish Goel
SEBI Registered Investment Adviser • Chartered Accountant
422 Articles Published
Manish Goel is a Chartered Accountant and the Founder of Multibagger Securities Research & Advisory Pvt. Ltd. (SEBI Registered Investment Adviser, INA100007736). A full-time value investor since 2010, he has helped thousands of investors build long-term wealth through quality stock picking and disciplined fundamental analysis.
April 28, 2026
Interest Coverage Ratio (EBIT/Finance Costs) is the 30-second solvency filter every Indian value investor must know. Titan Biotech FY25's ~₹3 Cr borrowings, ₹11 Cr internally funded CWIP, and 103% CFO/Operating Profit illustrate what fortress-coverage looks like in numbers.
April 28, 2026
Sir John Templeton's 'buy at the point of maximum pessimism' rule is the most uncomfortable, most lucrative discipline in value investing. Here's how Indian value investors can apply it in 2026 — and why durable, debt-free compounders are the right business-side filter.
April 27, 2026
Free Cash Flow Margin = (CFO − Capex) ÷ Revenue. Titan Biotech FY25 audited CFO/Operating Profit 103%, ₹3 Cr borrowings, ~₹214 Cr revenue — educational illustration of disciplined cash generation.
April 27, 2026
Regret aversion — the dread of taking a decision that will look like a mistake in hindsight — explains why Indian retail wealth stays parked in low-real-return FDs while equity SIPs deliver 14–16% CAGR. This article unpacks Bell (1982) and Loomes-Sugden (1982) regret theory, the Indian retail manifestations across SEBI/AMFI data, six structural counter-measures, and an illustrative case study of how Titan Biotech FY25 audited numbers (₹3 Cr borrowings, 103% CFO/Operating Profit, 36.4% independent board) demonstrate anti-regret process discipline at the corporate level.
